StockData

Delcath Systems vs InfuSystem

DCTH and INFU side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DCTH and INFU compare

Delcath Systems is the larger company, worth 2.3 times as much as InfuSystem ($672M against $295M).

On earnings, InfuSystem is cheaper: it trades at 36.1× trailing earnings, against 1937× for Delcath Systems.

Delcath Systems grew revenue faster over the last twelve months (35.8% versus 2.5% for InfuSystem).

InfuSystem keeps more of each dollar of sales as profit, with a net margin of 6.0% compared with 0.56% at Delcath Systems.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDCTHINFU
Size and price
Market cap$672M$295M
Share price$19.37$14.79
Change, 1 year117%55.5%
Change, 5 years98.9%−13.4%
Beta (5Y)1.980.84
Employees156473
StockData Score
Total score1313
Valuation score01 (better)
Growth score4 (better)2
Performance score34 (better)
Health score66
Dividend score00
Valuation
P/E1937×36.1× (better)
P/S7.0×2.1× (better)
P/B5.5×5.0× (better)
EV/EBITDA–11.9×
P/FCF38.4×12.9× (better)
FCF yield2.6%7.8% (better)
Fair value–$14.49
Margin of safety–−2.1%
Growth
Revenue growth (TTM)35.8% (better)2.5%
Revenue growth, 5Y average–8.1%
Net income growth (TTM)−76.2%68.4% (better)
EPS growth (TTM)−80.0%78.3% (better)
EPS growth, 5Y average–−17.3%
Profitability
Gross margin87.1% (better)57.5%
Operating margin−1.9%9.3% (better)
Net margin0.56%6.0% (better)
FCF margin18.3% (better)16.0%
Return on equity0.47%15.0% (better)
Return on invested capital−3.7%11.7% (better)
Financial health
Debt / equity0.000.35 (better)
Net debt / EBITDA–0.74
Interest coverage–12.1×
Current ratio9.83 (better)2.50
Altman Z-score21.70 (better)5.91
Piotroski F-score78 (better)
Dividends and buybacks
Buyback yield−0.09%2.7% (better)
Shareholder yield−0.09%2.7% (better)
Ownership
Held by institutions50.2%79.1%
Held by insiders37.4%12.2%
Insider net buying, 12 months−$338K$150K (better)
Short interest, % of float8.2%3.9%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.